London: Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumours, in some patients.A team led by scientists at The University of Texas MD Anderson Cancer Center has identified an unexpected mechanism that drives the drug’s attack on heart muscle, providing a new approach for identifying patients who can safely tolerate doxorubicin and for developing new drugs. “Even in this age of targeted therapies, doxorubicin remains an effective agent used mainly in combination with other drugs against a variety of malignancies, including breast, lung, ovarian and bladder cancers, as well as leukemia and lymphoma,” said Edward T.H. Yeh, M.D., professor and chair of MD Anderson’s Department of Cardiology and senior author of the study.“However, its use is limited by its cardiotoxicity, which can lead to heart failure. We’re excited because we’ve identified the molecular basis for doxorubicin’s damage to the heart,” Yeh said.
UPSC exam row: Students continue protests; 2 metro stations closed
Agra: 9 women dream of hidden `Kali` idol underground
Rajesh Khanna`s bungalow sold?
Complete trial against corrupt MPs within a year: PM Modi